Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.

被引：200

作者：

Chrysostomou, A ^{[1
]}

Becker, G ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Parkville, Vic 3052, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 345卷 / 12期

关键词：

D O I：

10.1056/NEJM200109203451215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：925 / 926

页数：2

相关论文

共 5 条

[1] Role of aldosterone in the remnant kidney model in the rat
Greene, EL
Kren, S
Hostetter, TH
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) : 1063 - 1068
[2] ESCAPE OF ALDOSTERONE PRODUCTION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION TREATED WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - IMPLICATIONS FOR THERAPY
PITT, B
[J]. CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (01) : 145 - 149
[3] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Pitt, B
Zannad, F
Remme, WJ
Cody, R
Castaigne, A
Perez, A
Palensky, J
Wittes, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
[4] ADRENALECTOMY AMELIORATES ABLATIVE NEPHROPATHY IN THE RAT INDEPENDENTLY OF CORTICOSTERONE MAINTENANCE LEVEL
QUAN, ZY
WALSER, M
HILL, GS
[J]. KIDNEY INTERNATIONAL, 1992, 41 (02) : 326 - 333
[5] Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
Taal, MW
Brenner, BM
[J]. KIDNEY INTERNATIONAL, 2000, 57 (05) : 1803 - 1817